Copyright

(c) 2010-2025 Jon L Gelman, All Rights Reserved.
Showing posts with label Biomarkers. Show all posts
Showing posts with label Biomarkers. Show all posts

Saturday, May 31, 2025

Unmasking Asbestos's Genetic Fingerprint

The recently published study, "From asbestos exposure to carcinogenesis: Transcriptomic signatures in malignant pleural mesothelioma", identifies specific gene expression patterns (differentially expressed genes, or DEGs) in patients with malignant pleural mesothelioma (MPM) who have a documented history of asbestos exposure. The research deepens our understanding of the molecular changes that occur due to asbestos-induced carcinogenesis.

Friday, September 16, 2022

Establishing Causal Relationship: Long COVID Biomarkers

Identifiable biomarkers may provide objective evidence in proving a Long COVID claim. A recent report highlights developments in identifying the risk of Long COVID through immune profiling.